Home › Trial NCT04666220
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma
- Trial IDNCT04666220
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorHumanitas Clinical and Research Center
- Enrollment180
- Start date2021-01-02
- ConditionsRenal Cell Carcinoma · Adrenal Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.